Mektovi 15 mg

MEKTOVI 15 MG tablets are a prescription medication used to treat certain types of cancer. This oral tablet, manufactured by Pfizer Canada ULC, contains the active ingredient binimetinib. Learn more about its uses and effects.

MEKTOVI 15 MG tablets are typically used in the treatment of advanced or metastatic melanoma with a specific genetic mutation. Binimetinib, the active ingredient, works by targeting certain proteins involved in cancer cell growth. This medication is often prescribed as part of a combination therapy to manage cancer progression.

Common effects of MEKTOVI 15 MG tablets may include fatigue, nausea, and diarrhea. Some users might experience skin reactions or changes in blood cell counts. It's important to discuss any persistent or severe effects with a healthcare provider.

MEKTOVI 15 MG tablets should be handled with care and stored as directed. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies. Always follow the advice of a healthcare professional regarding its use.

MEKTOVI 15 MG tablets may interact with other medications, including those metabolized by the liver. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect how this medication works.